Hydrochlorothiazide

Hydrochlorothiazide is a thiazide diuretic taken by mouth. The US label read is for hydrochlorothiazide tablets and lists two uses: adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy (the label also names edema from kidney disease as a use it has been found useful for); and the management of hypertension, as the sole agent or, in the more severe forms of hypertension, to enhance other antihypertensive drugs. The label's separate passage on diuretics in pregnancy was not recorded. Combination products that contain hydrochlorothiazide have their own labels and are not described here.

Also called HCTZ

  • Drug
  • In this atlas

Overview

Technical summary

RxNorm ingredient 5487; UNII 0J48LPH2TH. MeSH descriptor D006852 is Hydrochlorothiazide. Class: Thiazide Diuretic (FDA established pharmacologic class, RxClass). The label read is the hydrochlorothiazide tablets, Aurobindo Pharma Limited label, effective 2024-06-26 in openFDA (application ANDA040780). Other hydrochlorothiazide labels in openFDA, from other sponsors and repackagers, were not read. This page records label indications and the class only: no trial result and no dose is given.

Trials at a glance

The figures count the 16 registry trials in this atlas that name this drug or a product that contains it. Trials that use another name for it are not counted.

Trials
16
Phase 3 or 4
12
Recruiting
0
Regulatory decisions
0
Trials by phase (rows) and registry status (columns)
PhaseCompletedTerminatedUnknown statusAll statuses
Phase 23003
Phase 2/31001
Phase 33115
Phase 43047
All phases101516

Conditions these trials study

Sponsors with the most trials

The lead sponsor of each trial, as the registry names it.

And 9 more.

About this drug

Level
Substance
Mechanism
Not reported

Claims and evidence

Context People for whom the US label of hydrochlorothiazide tablets lists an indication: edema (including edema of congestive heart failure), hypertension

Recipient
Recipient not specified
Population
Patients described in the indications section of the label. The label does not state an age range in the passages read.
Care setting
Prescription medicine, as described in the US label
Geography
United States (label of the US Food and Drug Administration)
Life stage
Not stated in the label passages read
Gestational age
Not reported
Postnatal age
Not reported
Follow-up
Not applicable (label statement)
Eligibility: 2 inclusion criteria; exclusion criteria not stated
Included
Excluded
None stated
  • Description Evidence stage not applicable Certainty not assessed

    The US label of hydrochlorothiazide tablets, in the Aurobindo Pharma Limited version dated 2024-06-26 in openFDA, lists the medicine as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy, and in the management of hypertension, either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension.

    Applies to Recipient not specified People for whom the US label of hydrochlorothiazide tablets lists an indication: edema (including edema of congestive heart failure), hypertension

    Certainty method
    Not assessed
    Limitations
    This claim records what the label says the medicine is indicated for. It is not a finding about how well the medicine works, and no trial result is recorded for it in this atlas. The label may list other indications that were not recorded. Contraindications, doses, interactions and warnings were not read. Labels change, and openFDA also lists other versions with different dates. openFDA's own disclaimer says not to rely on it for decisions about medical care.
    Last checked
    2026-11-09
    Next evidence check due
    Not scheduled
    Sources and citations (2)
    1. Supports openFDA drug label record for hydrochlorothiazide tablets, Aurobindo Pharma Limited label: indications and substance identifiers

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 01f1f478-5493-439f-9b99-f4f82023781c (manufacturer Aurobindo Pharma Limited, application ANDA040780), returned on 2026-11-09. The label text is dated 2024-06-26 (effective_time). Other openFDA records of hydrochlorothiazide labels from other sponsors and repackagers exist and were not used.

      Locator
      results[0].indications_and_usage[0]
      How it applies
      The label sentences that give the indications named in the statement, each quoted in the research quote table.
      Retrieved
      Source effective date
      2024-06-26
      Source state
      Current
      Version fingerprint
      cc53f95717d74809d63ae95a14078f0ca4d3da6de792140deebbaf4f025c5549
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.
    2. Background openFDA drug label record for hydrochlorothiazide tablets, Aurobindo Pharma Limited label: indications and substance identifiers

      Regulator · U.S. Food and Drug Administration (openFDA) · Edition The openFDA drug label record for set id 01f1f478-5493-439f-9b99-f4f82023781c (manufacturer Aurobindo Pharma Limited, application ANDA040780), returned on 2026-11-09. The label text is dated 2024-06-26 (effective_time). Other openFDA records of hydrochlorothiazide labels from other sponsors and repackagers exist and were not used.

      Locator
      results[0].effective_time
      How it applies
      Effective date of the label text read, 20240626.
      Retrieved
      Source effective date
      2024-06-26
      Source state
      Current
      Version fingerprint
      cc53f95717d74809d63ae95a14078f0ca4d3da6de792140deebbaf4f025c5549
      Reuse basis
      openFDA data is public domain under a Creative Commons CC0 1.0 Universal dedication, as the openFDA licence page states (fetched 2026-11-09, sha256 7fda0041a24f8d7139a1781d4462ae39643a2ee6f3b0f079946c989a8e1982d2, hash only). Only short passages are quoted. The raw record is committed in the atlas repository.

FDA label

The FDA label of the application holder, as the openFDA label dataset holds it, for the products that contain this drug.

ACCURETIC

No label from the application holder was found in the openFDA label dataset for application NDA020125. This page does not show another labeler's label in its place.

ALDACTAZIDE

No label from the application holder was found in the openFDA label dataset for application NDA012616. This page does not show another labeler's label in its place.

ALDORIL 15

No label from the application holder was found in the openFDA label dataset for application NDA013402. This page does not show another labeler's label in its place.

AMTURNIDE

No label from the application holder was found in the openFDA label dataset for application NDA200045. This page does not show another labeler's label in its place.

ATACAND HCT

No label from the application holder was found in the openFDA label dataset for application NDA021093. This page does not show another labeler's label in its place.

AVALIDE

No label from the application holder was found in the openFDA label dataset for application NDA020758. This page does not show another labeler's label in its place.

BENICAR HCT

No label from the application holder was found in the openFDA label dataset for application NDA021532. This page does not show another labeler's label in its place.

CAPOZIDE 25/15

No label from the application holder was found in the openFDA label dataset for application NDA018709. This page does not show another labeler's label in its place.

DIOVAN HCT

No label from the application holder was found in the openFDA label dataset for application NDA020818. This page does not show another labeler's label in its place.

DUTOPROL

No label from the application holder was found in the openFDA label dataset for application NDA021956. This page does not show another labeler's label in its place.

DYAZIDE

No label from the application holder was found in the openFDA label dataset for application NDA016042. This page does not show another labeler's label in its place.

ESIDRIX

No label from the application holder was found in the openFDA label dataset for application NDA011793. This page does not show another labeler's label in its place.

EXFORGE HCT

No label from the application holder was found in the openFDA label dataset for application NDA022314. This page does not show another labeler's label in its place.

HYDRODIURIL

No label from the application holder was found in the openFDA label dataset for application NDA011835. This page does not show another labeler's label in its place.

HYDROPRES 25

No label from the application holder was found in the openFDA label dataset for application NDA011958. This page does not show another labeler's label in its place.

HYZAAR

No label from the application holder was found in the openFDA label dataset for application NDA020387. This page does not show another labeler's label in its place.

INDERIDE LA 80/50

No label from the application holder was found in the openFDA label dataset for application NDA019059. This page does not show another labeler's label in its place.

INDERIDE-40/25

No label from the application holder was found in the openFDA label dataset for application NDA018031. This page does not show another labeler's label in its place.

INZIRQO

No label from the application holder was found in the openFDA label dataset for application NDA219141. This page does not show another labeler's label in its place.

LOPRESSOR HCT

No label from the application holder was found in the openFDA label dataset for application NDA018303. This page does not show another labeler's label in its place.

LOTENSIN HCT

No label from the application holder was found in the openFDA label dataset for application NDA020033. This page does not show another labeler's label in its place.

MAXZIDE

No label from the application holder was found in the openFDA label dataset for application NDA019129. This page does not show another labeler's label in its place.

MICARDIS HCT

No label from the application holder was found in the openFDA label dataset for application NDA021162. This page does not show another labeler's label in its place.

MICROZIDE

No label from the application holder was found in the openFDA label dataset for application NDA020504. This page does not show another labeler's label in its place.

MODURETIC 5-50

No label from the application holder was found in the openFDA label dataset for application NDA018201. This page does not show another labeler's label in its place.

MONOPRIL-HCT

No label from the application holder was found in the openFDA label dataset for application NDA020286. This page does not show another labeler's label in its place.

NORMOZIDE

No label from the application holder was found in the openFDA label dataset for application NDA019046. This page does not show another labeler's label in its place.

ORETIC

No label from the application holder was found in the openFDA label dataset for application NDA011971. This page does not show another labeler's label in its place.

ORETICYL 25

No label from the application holder was found in the openFDA label dataset for application NDA012148. This page does not show another labeler's label in its place.

PRINZIDE

No label from the application holder was found in the openFDA label dataset for application NDA019778. This page does not show another labeler's label in its place.

SER-AP-ES

No label from the application holder was found in the openFDA label dataset for application NDA012193. This page does not show another labeler's label in its place.

SERPASIL-ESIDRIX #1

No label from the application holder was found in the openFDA label dataset for application NDA011878. This page does not show another labeler's label in its place.

TEKTURNA HCT

No label from the application holder was found in the openFDA label dataset for application NDA022107. This page does not show another labeler's label in its place.

TEVETEN HCT

No label from the application holder was found in the openFDA label dataset for application NDA021268. This page does not show another labeler's label in its place.

TIMOLIDE 10-25

No label from the application holder was found in the openFDA label dataset for application NDA018061. This page does not show another labeler's label in its place.

TRIBENZOR

No label from the application holder was found in the openFDA label dataset for application NDA200175. This page does not show another labeler's label in its place.

UNIRETIC

No label from the application holder was found in the openFDA label dataset for application NDA020729. This page does not show another labeler's label in its place.

VASERETIC

No label from the application holder was found in the openFDA label dataset for application NDA019221. This page does not show another labeler's label in its place.

ZESTORETIC

No label from the application holder was found in the openFDA label dataset for application NDA019888. This page does not show another labeler's label in its place.

ZIAC

No label from the application holder was found in the openFDA label dataset for application NDA020186. This page does not show another labeler's label in its place.

FDA decisions timeline

The regulatory decisions of the FDA that this atlas holds for this drug and the products that contain it, oldest first. Each links to its full record.

  1. Approval NDA011793 ESIDRIX
  2. Approval NDA011835 HYDRODIURIL
  3. Approval NDA011878 SERPASIL-ESIDRIX #1
  4. Approval NDA011971 ORETIC
  5. Approval NDA012148 ORETICYL 25
  6. Approval NDA012193 SER-AP-ES
  7. Approval NDA012616 ALDACTAZIDE
  8. Approval NDA013402 ALDORIL 15
  9. Approval NDA016042 DYAZIDE
  10. Approval NDA011958 HYDROPRES 25
  11. Approval NDA018031 INDERIDE-40/25
  12. Approval NDA018201 MODURETIC 5-50
  13. Approval NDA018061 TIMOLIDE 10-25
  14. Approval NDA018709 CAPOZIDE 25/15
  15. Approval NDA019129 MAXZIDE
  16. Approval NDA018303 LOPRESSOR HCT
  17. Approval NDA019059 INDERIDE LA 80/50
  18. Approval NDA019221 VASERETIC
  19. Approval NDA019046 NORMOZIDE
  20. Supplemental approval NDA018061 TIMOLIDE 10-25
  21. Supplemental approval NDA019129 MAXZIDE
  22. Approval NDA019778 PRINZIDE
  23. Approval NDA019888 ZESTORETIC
  24. Supplemental approval NDA018031 INDERIDE-40/25
  25. Supplemental approval NDA018709 CAPOZIDE 25/15
  26. Approval NDA020033 LOTENSIN HCT
  27. Supplemental approval NDA011835 HYDRODIURIL
  28. Approval NDA020186 ZIAC
  29. Supplemental approval NDA019778 PRINZIDE
  30. Supplemental approval NDA019888 ZESTORETIC
  31. Supplemental approval NDA016042 DYAZIDE
  32. Approval NDA020286 MONOPRIL-HCT
  33. Approval NDA020387 HYZAAR
  34. Supplemental approval NDA019221 VASERETIC
  35. Approval NDA020504 MICROZIDE
  36. Approval NDA020729 UNIRETIC
  37. Approval NDA020758 AVALIDE
  38. Approval NDA020818 DIOVAN HCT
  39. Approval NDA020125 ACCURETIC
  40. Approval NDA021093 ATACAND HCT
  41. Approval NDA021162 MICARDIS HCT
  42. Approval NDA021268 TEVETEN HCT
  43. Supplemental approval NDA020818 DIOVAN HCT
  44. Approval NDA021532 BENICAR HCT
  45. Supplemental approval NDA020387 HYZAAR
  46. Supplemental approval NDA020387 HYZAAR
  47. Supplemental approval NDA020387 HYZAAR
  48. Supplemental approval NDA020818 DIOVAN HCT
  49. Approval NDA021956 DUTOPROL
  50. Supplemental approval NDA020758 AVALIDE
  51. Approval NDA022107 TEKTURNA HCT
  52. Supplemental approval NDA020818 DIOVAN HCT
  53. Supplemental approval NDA018061 TIMOLIDE 10-25
  54. Approval NDA022314 EXFORGE HCT
  55. Supplemental approval NDA022107 TEKTURNA HCT
  56. Approval NDA200175 TRIBENZOR
  57. Approval NDA200045 AMTURNIDE
  58. Approval NDA219141 INZIRQO

Clinical links

Each link reports what one cited claim says about one population. "Evaluated for" means studied, not shown to work. These links do not show that anything is effective or right for you.

Registry records

Assembled by a program from ClinicalTrials.gov and openFDA. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry products 40

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and no efficacy supplement approvals on record.

    ProductNDA011793

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and 1 efficacy supplement approval on record.

    ProductNDA011835

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and no efficacy supplement approvals on record. FDA lists it under 2 brand...

    ProductNDA011878

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and no efficacy supplement approvals on record. FDA lists it under 2 brand...

    ProductNDA011958

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and no efficacy supplement approvals on record.

    ProductNDA011971

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and no efficacy supplement approvals on record. FDA lists it under 3 brand...

    ProductNDA012148

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and no efficacy supplement approvals on record.

    ProductNDA012193

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and no efficacy supplement approvals on record.

    ProductNDA012616

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and no efficacy supplement approvals on record. FDA lists it under 4 brand...

    ProductNDA013402

  • A new drug application (NDA) that FDA lists in Drugs@FDA, with an original approval and 1 efficacy supplement approval on record.

    ProductNDA016042

Registry trials 16

Record details

Record id
cardio:hydrochlorothiazide
Content hash
0b2f5bf56f0ca2a1367a7afa16c5d7ca76a978812607810c987c4427ad322e45